<?xml version="1.0" encoding="UTF-8"?>
<p>First‐line treatments used for prophylaxis of malaria, amebiasis, and autoimmune diseases such as rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus inhibit the proliferation of several DNA and RNA‐containing viruses, including coronaviruses. There is some evidence that chloroquine is effective in animal models of mice on viruses such as human coronavirus OC43, enterovirus EV‐A71, Zika virus, and influenza A H5N1 virus. It is also active in ex vivo conditions on Ebola virus in mice (T. Sheahan et al., 
 <xref rid="jcp29785-bib-0047" ref-type="ref">2017</xref>; Tan, Yam, Sun, &amp; Chu, 
 <xref rid="jcp29785-bib-0053" ref-type="ref">2018</xref>; Yan et al., 
 <xref rid="jcp29785-bib-0064" ref-type="ref">2013</xref>).
</p>
